| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.05 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |